NASDAQ$OFIX
Orthofix Medical Inc · Q3 2020 earnings
Q3 2020 earnings · · Investor relations
Briefing
Reported strong execution and leadership amidst COVID-19 uncertainty, highlighted by sequential global net sales growth.
Orthofix reported a net sales of $111.0 million, EPS of $0.24, and adjusted EPS of $0.31 for Q3 2020. The U.S. spinal implants business grew 19% over the third quarter of 2019.
- Net sales increased 52% sequentially and were within 2% of 2019 performance.
- US Spinal Implants net sales increased 19% over the prior year.
- Motion Preservation sales in the U.S. increased 44% sequentially and over 400% over prior year.
- Entered into an investment and co-development partnership with Neo Medical SA.
Headline financials
Revenue & EPS history
Orthofix · Revenue · Quarterly
$111M
Revenue by segment
Orthofix · $72.6M total across 2 segments · Q3 2020
- Bone Growth Therapies$47.1M-3.6%64.9%
- Spinal Implants & Biologics$25.5M+11.1%35.1%
Forward guidance
Due to the uncertainty of the COVID-19 pandemic and its potential effects, the Company is not providing quantitative guidance for the fourth quarter of 2020 at this time.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2020
-0.9%
Avg return
Earnings day
-2.6%
Avg return
5 days after
-3.4%
Avg return
30 days after
48%
31 / 65 earnings
Positive
+20.3%
Q2 2014
Best reaction
-18.5%
Q4 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.8% | -2.8% | -13.8% | |
| Q4 2025 | -7.0% | -0.4% | -13.2% | |
| Q3 2025 | -7.4% | -6.8% | -1.0% | |
| Q1 2025 | -10.8% | -10.6% | -20.9% | |
| Q4 2024 | -3.5% | -4.2% | -11.0% | |
| Q3 2024 | +5.5% | +4.6% | +1.2% | |
| Q2 2024 | +13.8% | +10.8% | +16.7% | |
| Q1 2024 | +10.7% | +8.8% | +0.6% | |
| Q4 2023 | +8.1% | +7.1% | +8.6% | |
| Q3 2023 | -12.5% | -20.2% | -3.2% | |
| Q2 2023 | +9.9% | +7.6% | +1.3% | |
| Q1 2023 | +1.0% | -2.3% | +6.7% | |
| Q4 2022 | -7.7% | -13.2% | -15.5% | |
| Q3 2022 | -2.2% | +4.1% | +30.5% | |
| Q2 2022 | -6.6% | -8.8% | -20.9% | |
| Q1 2022 | -10.5% | -14.3% | -11.6% | |
| Q4 2021 | +4.0% | +3.5% | +0.4% | |
| Q3 2021 | -5.9% | -10.9% | -18.6% | |
| Q2 2021 | +8.9% | +4.1% | +12.4% | |
| Q1 2021 | +0.5% | -2.0% | -8.7% | |
| Q4 2020 | +0.6% | -0.5% | -7.3% | |
| Q3 2020 | +5.2% | +13.6% | +10.8% | |
| Q2 2020 | +4.5% | +4.6% | -13.4% | |
| Q1 2020 | -1.9% | -6.9% | +3.9% | |
| Q4 2019 | -18.5% | -21.5% | -40.9% | |
| Q3 2019 | -16.8% | -17.0% | -9.6% | |
| Q2 2019 | +0.1% | +2.6% | -5.5% | |
| Q1 2019 | -2.6% | -0.3% | -10.9% | |
| Q4 2018 | -8.5% | -10.0% | -14.8% | |
| Q3 2018 | +7.4% | +8.8% | +4.1% | |
| Q2 2018 | -15.1% | -11.9% | -12.1% | |
| Q1 2018 | -13.4% | -14.6% | -10.5% | |
| Q4 2017 | +6.4% | +4.6% | +8.4% | |
| Q3 2017 | +8.8% | +5.1% | +9.6% | |
| Q2 2017 | +9.9% | +6.8% | +12.3% | |
| Q1 2017 | +1.4% | +3.8% | +8.2% | |
| Q4 2016 | -6.1% | -4.8% | +2.6% | |
| Q3 2016 | -3.8% | -6.8% | -1.5% | |
| Q2 2016 | -10.4% | -10.5% | -4.8% | |
| Q1 2016 | +0.4% | — | — | |
| Q4 2015 | +2.8% | — | — | |
| Q3 2015 | +14.4% | — | — | |
| Q2 2015 | +13.8% | — | — | |
| Q1 2015 | +0.4% | — | — | |
| Q4 2014 | -10.8% | — | — | |
| Q3 2014 | +20.3% | — | — | |
| Q2 2014 | +20.3% | — | — | |
| Q1 2014 | +4.2% | — | — | |
| Q4 2013 | +14.1% | — | — | |
| Q3 2013 | +1.1% | — | — | |
| Q2 2013 | -0.8% | — | — | |
| Q1 2013 | -16.4% | — | — | |
| Q4 2012 | -4.9% | — | — | |
| Q3 2012 | -2.8% | — | — | |
| Q2 2012 | +4.5% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q1 2012 | +1.0% | — | — | |
| Q1 2010 | -4.8% | — | — | |
| Q4 2011 | -4.8% | — | — | |
| Q4 2009 | -4.8% | — | — | |
| Q3 2010 | -7.4% | — | — | |
| Q3 2011 | -7.4% | — | — | |
| Q4 2010 | -9.5% | — | — | |
| Q2 2010 | -9.5% | — | — | |
| Q2 2011 | -9.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro